Ipratropium Bromide Solution
Product Images NDC 67296-2246

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 67296-2246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

25 Ct Brick Carton (Rpsc0269 Rdp 0.02 25 Ct Brick Carton)

Box packaging label for Ipratropium Bromide Inhalation Solution, 0.02%, containing 0.5 mg/2.5 mL sterile unit-dose vials. The label indicates it is for oral inhalation only, Rx only, with a package size of 25 x 2.5 mL vials. The manufacturer is identified as Ritedose Pharmaceuticals.*

FDA Label Image

30 Ct Brick Carton (Rpsc0270 Rdp 0.02 30 Ct Brick Carton)

The image shows a flat, unfolded carton label for Ipratropium Bromide Inhalation Solution, 0.02%, at a strength of 0.5 mg/2.5 mL. The label highlights that the solution is for oral inhalation only and is provided in 30 single-dose vials of 2.5 mL each. The labeler is Redpharm Drug, and the product includes the NDC 67296-100-30.*

FDA Label Image

60 Ct Brick Carton (Rpsc0271 Rdp 0.02 60 Ct Brick Carton)

Box packaging label for Ipratropium Bromide Inhalation Solution 0.5 mg/2.5 mL (0.02%) by Redpharm Drug, NDC 67296-2246. The label indicates it is for oral inhalation only and contains 60 x 2.5 mL sterile unit-dose vials. The design features blue, green, and white colors with text emphasizing the prescription-only status.*

FDA Label Image

30 Ct Singles Carton (Rpsc0300 Rdp 0.02 30 Ct Singles Carton)

Box packaging label for Ipratropium Bromide Inhalation Solution, 0.5 mg/2.5 mL by Redpharm Drug. The label displays the product name, strength, inhalation solution form, and instructions for oral inhalation use only. Features barcodes and the labeler name "RITE DOSE Pharmaceuticals," along with the NDC number 67296-2246. The design includes green highlighting around the strength and a small vial image.*

FDA Label Image

Chemical Structure (Ipratropium 01)

Chemical structure of Ipratropium Bromide as depicted in the image, showing its molecular configuration including the bromide ion and associated water molecule.*

FDA Label Image

Figure 1 (Ipratropium 02)

An instructional illustration labeled Figure 1 shows a hand holding a small vial upside-down. The vial is dotted in the middle section. The image demonstrates a step in the preparation or usage of the vial contents, likely related to inhalation solution administration.*

FDA Label Image

Figure 2 (Ipratropium 03)

An instructional illustration labeled Figure 2 showing a close-up of a hand manipulating a component of an inhalation device by sliding or moving it horizontally, indicated by two arrows pointing in opposite directions. The image likely demonstrates part of the device operation or assembly process.*

FDA Label Image

Figure 3 (Ipratropium 04)

An instructional diagram labeled Figure 3 showing the side profile of a person holding a respiratory inhalation device close to their mouth preparing to use it. The image highlights proper positioning for inhaling the solution dosage form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.